Back to Journals » Cancer Management and Research » Volume 13

Evaluation of the Benefits of TACE Combined with Sorafenib for Hepatocellular Carcinoma Based on Untreatable TACE (unTACEable) Progression

Total article views   HTML views PDF downloads Totals
5,687 Dovepress* 5,231+ 636 5,867
PubMed Central* 456 182 638
Totals 5,687 818 6,505
*Since 18 May 2021
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 0 2 2

View citations on PubMed Central and Google Scholar